Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreo Medical Regulatory News (CREO)

Share Price Information for Creo Medical (CREO)

Share Price is delayed by 15 minutes
Get Live Data
13.50    0.00 (0.00%)
Bid:
13.25
Ask:
13.75
Spread: 0.50 (3.774%)
Market Cap: £65.58m
CREO Live PriceLast checked at - London Stock Exchange

Intraday Creo Medical Share Chart

City Centre Development

17 Jun 2010 07:00

RNS Number : 7721N
China Real Estate Opportunities PLC
17 June 2010
 



 

CHINA REAL ESTATE OPPORTUNITIES PLC

RECEIPT OF LETTERS FROM VENDORS OF CITY CENTER

 

China Real Estate Opportunities plc ("CREO" or the "Company"), is an AIM-listed company established to acquire investment and development properties in China.

 

On 24 May 2010 and 10 June 2010, CREO and CREO (Shanghai City Centre) Limited (which is a wholly-owned subsidiary of CREO) ("CSCCL") received letters (the "Letters") from the vendors of the City Center property (the "Vendors") requesting certain information, and alleging that certain conditions under the Share Purchase Agreement (as defined below and which was entered into in June 2007) may have occurred or may be likely to occur. If substantiated, the allegation may potentially result in a future payment by CREO of an amount of up to approximately GBP14 million to the Vendors (as defined below).

 

CSCCL and CREO have obtained advice and opinions from both Hong Kong and Peoples Republic of China counsel indicating that the request for information has no basis and any alleged claim for payment as set forth in the Letters have no merit. Accordingly, CSCCL and CREO intend to defend their position vigorously. CSCCL and CREO are of the view that the Letters have been sent at an opportunistic time in light of the impending listing by introduction of Treasury China Trust on Singapore Exchange Securities Trading Limited (the "SGX-ST").

 

CREO will make further announcements as and when there are material developments in the above matters.

 

The City Center Share Purchase Agreement

On 1 June 2007, CSCCL and CREO entered into a share purchase agreement in respect of the acquisition by CSCCL of Brightime Limited and State Properties Limited (the "Share Purchase Agreement") from the Vendors. Brightime Limited and State Properties Limited, through their wholly owned subsidiary Shanghai Hua Tian Property Development Co., Ltd. ("Hua Tian"), own the City Center property in Shanghai.

 

Contact:

 

CREO

Ray Horney, Chairman

Tel: 07797 314 1596

 

Sarah Moriarty, Investor Relations

Tel: +353 1 6189455

 

Matrix Corporate CapitalPaul Fincham Tel +44 (0)20 3206 7000

 

Davy

Des Carville

Tel: +353 1 679 6363

 

Citigate Dewe Rogerson

Tom Baldock

Tel: + 44 (0) 20 7638 9571

 

Murray Consultants

Ed Micheau

Tel: + 3531 498 0300

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUBOVRRNANARR
Date   Source Headline
10th May 20197:00 amRNSMello 2019
24th Apr 20197:00 amRNSNew video abstract featuring Speedboat published
5th Apr 20197:00 amRNSFinal Results
28th Mar 20197:00 amRNSUpdate on US Clinical Education Programme
21st Mar 20192:34 pmRNSExercise of Options
21st Mar 20197:00 amRNSNotice of results and investor briefing
18th Mar 20197:00 amRNSCreo founder in Sunday Times 100 UK entrepreneurs
14th Mar 20195:17 pmRNSHolding(s) in Company
12th Mar 20199:19 amRNSSpeedboat in BSG Endoscopy best video abstract
6th Mar 201912:58 pmRNSExercise of Options
11th Feb 20197:00 amRNSDistribution agreement for France, Germany, Italy
24th Jan 201911:17 amRNSGrowth & Innovation Forum 2019
16th Jan 20197:00 amRNSFirst use of Speedboat in the US
17th Dec 20184:28 pmRNSExercise of Options
3rd Dec 20187:00 amRNSFirst placement and use of Speedboat in Europe
23rd Nov 201810:43 amRNSDirector/PDMR Shareholding
19th Nov 20181:30 pmRNSExercise of Options
22nd Oct 20182:52 pmRNSHolding(s) in Company
19th Oct 20187:00 amRNSUK Endoscopy Training Course
17th Oct 20187:00 amRNSSpain & Benelux Framework Distribution Agreements
12th Oct 20187:00 amRNSHolding(s) in Company
8th Oct 20187:00 amRNSInvestor Open Event at Chepstow
3rd Oct 201812:14 pmRNSHolding(s) in Company
28th Sep 20187:00 amRNSInterim results for six months ended 30 June 2018
17th Sep 20187:04 amRNSExtension of Distribution Agreement with Pentax
13th Sep 20187:00 amRNSFirst use of Speedboat in South Africa
3rd Sep 20181:34 pmRNSHolding(s) in Company
31st Aug 201811:32 amRNSHolding(s) in Company
31st Aug 201811:30 amRNSDirector/PDMR Shareholding
21st Aug 20183:59 pmRNSIssue of Equity Update - Amendment
21st Aug 20181:48 pmRNSIssue of Equity Update
20th Aug 201810:13 amRNSDirector/PDMR Shareholding
1st Aug 20181:24 pmRNSResult of General Meeting
18th Jul 20184:44 pmRNSHolding(s) in Company
13th Jul 20187:00 amRNSConditional Placing of New Ordinary Shares
9th Jul 20187:00 amRNSAgreement with First Medical Company
4th Jul 20187:00 amRNSUK Distribution Agreement with Diagmed Healthcare
2nd Jul 20187:00 amRNSMarket Update
10th May 201811:25 amRNSExercise of Options
20th Apr 20184:38 pmRNSChange of accounting reference date
20th Mar 20187:00 amRNSInterim results for six months to 31 December 2017
28th Feb 20184:32 pmRNSChange of Registered Office
12th Feb 20187:00 amRNSExercise of Options
9th Jan 20185:43 pmRNSDirector/PDMR Shareholding
22nd Dec 201712:10 pmRNSDirector/PDMR Shareholding
22nd Dec 20179:24 amRNSDirector/PDMR Shareholding
20th Dec 20171:32 pmRNSResult of AGM
29th Nov 20177:00 amRNSSpeedboat RS2 advances beyond initial pilot centre
24th Nov 201710:49 amRNSNotice of AGM
14th Nov 20177:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.